secwatch.observer — SEC 8-K summary
======================================

Issuer:     FATE THERAPEUTICS INC (FATE)
CIK:        0001434316
Form:       8-K
Filed at:   2023-11-08T23:59:59+00:00
Accession:  0001193125-23-273633
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 1.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Fate Therapeutics files $300M shelf, enters $100M ATM with Jefferies; terminates prior agreement
--------------------------------------------------------------------------------

- Filed S-3 shelf registration for up to $300M of common, preferred, debt, warrants, and units.
- Entered ATM offering agreement with Jefferies for up to $100M of common stock at market prices.
- Jefferies will receive a 3% commission on gross proceeds from any ATM sales.
- Prior ATM facility dated Nov 4, 2021 terminated and replaced by the new agreement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1434316/000119312523273633/0001193125-23-273633-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1434316/000119312523273633/d554381d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-273633

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer